A certified one-hour live and interactive webinar case review for radiologists
Click ENROLL NOW to register for this program
This series of five interactive webinars on liver, abdomen, body, breast, and brain will focus on challenging and difficult cases, stressing a practical, clinically-oriented approach to interpretation, diagnosis, and communication with referring physicians. The series will offer practitioners the opportunity to look over the shoulder of expert faculty and review cases not routinely encountered in daily practice. The principles and current status of clinical applications using the newest MRI methodologies and contrast media will be discussed in support of the case review and in response to questions that arise during the course of the series.
At the conclusion of this activity, participants should be better able to:
Credit CANNOT be granted for group viewing. To receive credit, EACH attendee must sign in on a separate computer.
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is offered by ICPME through WebEx webinar service.
Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.
There are no fees to participate in this activity. Each participant will need a computer with internet access.
Jeffrey C. Weinreb, MD, FACR
Professor of Diagnostic Radiology
Yale University School of Medicine
Director of Medical Imaging
Chief of Body Imaging
Chief of Magnetic Resonance Imaging
Yale-New Haven Hospital
After graduating Phi Beta Kappa from the Massachusetts Institute of Technology, Dr. Weinreb received his medical degree from the Mount Sinai School of Medicine. He has held faculty positions at University of Texas Medical School, Columbia College for Physicians and Surgeons, and New York University School of Medicine, where he was Director of MRI for 15 years and led a group that pioneered the development of Body MRI. Yale has been his home since 2002.
Dr. Weinreb is currently Professor of Diagnostic Radiology at the Yale School of Medicine and Chief of MRI and Director of Medical Imaging at Yale-New Haven Hospital. He is a leading authority in MRI contrast agents and the use of MRI for the breast, abdomen (focusing on the liver) and pelvis. A noted educator and lecturer, he has presented more than 800 invited lectures and has been a frequent Visiting Professor throughout the world. Dr. Weinreb has authored/co-authored more than 160 peer-reviewed manuscripts and three textbooks, and he is on the editorial boards of several medical journals.
As Chairman of the American College of Radiology Commission on Quality and Safety, Dr. Weinreb spearheaded efforts to improve the quality of medical imaging in the USA. He has served as President of the SCBT/MR, President of the New York Roentgen Society, Vice President of the ACR, and Chair of the annul ACR Forum. Dr. Weinreb continues to maintain a full-time clinical and academic practice.
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty below reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jeffrey C. Weinreb, MD, FACR has received consulting fees from Bayer HealthCare Pharmaceuticals, Boston Scientific, and CMC Contrast AB.
The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Sharon Cancino
Laura Excell, ND, NP, MS, MA, LPC, NCC
Trace Hutchison, PharmD
Julia Kimball, RN, BSN
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Bayer HealthCare Pharmaceuticals do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the view of PIM, ICPME and Bayer HealthCare Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860
JOINTLY SPONSORED BY
SUPPORTED BY AN EDUCATIONAL GRANT FROM
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.